Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-092506
Filing Date
2025-09-23
Accepted
2025-09-23 16:00:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8787
2 EXHIBIT 1 tm2526760d1_ex-1.htm EX-99.1 4873
  Complete submission text file 0001104659-25-092506.txt   15692
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
MILLENNIUM MANAGEMENT LLC (Filed by) CIK: 0001273087 (see all company filings)

EIN.: 133804139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Subject) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89797 | Film No.: 251333619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)